Magnetic resonance molecular imaging with nanoparticles

Journal of Nuclear Cardiology

Volumn 11, Issue 6, 2004, Pages 733-743

  Lanza, Gregory M ^a   Winter, Patrick M ^a   Caruthers, Shelton D ^a,b   Morawski, Anne M ^a   Schmieder, Anne H ^a   Crowder, Katherine C ^a   Wickline, Samuel A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PHILIPS HEALTHCARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA3 INTEGRIN; ASIALOFETUIN; AVIDIN; BETA3 INTEGRIN; BIOLOGICAL MARKER; DEXTRAN; EP 1873; FLUOROCARBON; FUMAGILLIN; GADOLINIUM PENTETATE; GALACTOSE; LIPOSOME; MONOCRYSTALLINE IRON OXIDE NANOPARTICLE; MYOSIN ANTIBODY; NANOPARTICLE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; SILICONE; STARCH; SUPERPARAMAGNETIC IRON OXIDE; TRASTUZUMAB; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG;

ANTIANGIOGENIC ACTIVITY; CELL SURFACE; DIAGNOSTIC IMAGING; DRUG COATING; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG TARGETING; HUMAN; MOLECULAR RECOGNITION; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL RESOLUTION; PARTICLE SIZE; PATHOLOGICAL ANATOMY; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

EID: 10944248079     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nuclcard.2004.09.002     Document Type: Article

References (67)

1. F. Gutierrez J. Brown S. Mirowitz Cardiovascular magnetic resonance imaging 1992 Mosby St Louis
2. K.L. Nelson V.M. Runge Basic principles of MR contrast Top Magn Reson Imaging 7 1995 124-136
3. S. Moghimi H. Patel Serum opsonins and phagocytosis of saturated and unsaturated phospholipid liposomes Biochim Biophys Acta 984 1989 384-387
4. L. Babes B. Denizot G. Tanguy J.J. Le Jeune P. Jallet Synthesis of iron oxide nanoparticles used as MRI contrast agents: A parametric study J Colloid Interface Sci 212 1999 474-482
5. I. Berry S. Benderbous J.P. Ranjeva D. Gracia-Meavilla C. Manelfe D. Le Bihan Contribution of Sinerem used as blood-pool contrast agent: detection of cerebral blood volume changes during apnea in the rabbit Magn Reson Med 36 1996 415-419
6. D. Van Gansbeke C. Matos T. Metens Vascular enhancement with superparamagnetic iron oxide AJR Am J Roentgenol 167 1996 813-814
7. A.E. Stillman N. Wilke D. Li M. Haacke S. McLachlan Ultrasmall superparamagnetic iron oxide to enhance MRA of the renal and coronary arteries: Studies in human patients J Comput Assist Tomogr 20 1996 51-55
8. Y. Anzai M.R. Prince T.L. Chenevert J.H. Maki F. Londy M. London et al. MR angiography with an ultrasmall superparamagnetic iron oxide blood pool agent J Magn Reson Imaging 7 1997 209-214
9. P. Loubeyre S. Zhao E. Canet H. Abidi S. Benderbous D. Revel Ultrasmall superparamagnetic iron oxide particles (AMI 227) as a blood pool contrast agent for MR angiography: Experimental study in rabbits J Magn Reson Imaging 7 1997 958-962
10. A. Moore E. Marecos A. Bogdanov Jr R. Weissleder Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model Radiology 214 2000 568-574
11. R.C. Semelka J.K. Lee S. Worawattanakul T.C. Noone R.H. Patt S.M. Ascher Sequential use of ferumoxide particles and gadolinium chelate for the evaluation of focal liver lesions on MRI J Magn Reson Imaging 8 1998 670-674
12. J. Scott J. Ward J.A. Guthrie D. Wilson P.J. Robinson MRI of liver: A comparison of CNR enhancement using high dose and low dose ferumoxide infusion in patients with colorectal liver metastases Magn Reson Imaging 18 2000 297-303
13. M. Nakayama Y. Yamashita K. Mitsuzaki T. Yi A. Arakawa K. Katahira et al. Improved tissue characterization of focal liver lesions with ferumoxide-enhanced T1 and T2-weighted MR imaging J Magn Reson Imaging 11 2000 647-654
14. K. Imam D.A. Bluemke MR imaging in the evaluation of hepatic metastases Magn Reson Imaging Clin N Am 8 2000 741-756
15. H. Kato M. Kanematsu H. Kondo S. Goshima M. Matsuo H. Hoshi et al. Ferumoxide-enhanced MR imaging of hepatocellular carcinoma: Correlation with histologic tumor grade and tumor vascularity J Magn Reson Imaging 19 2004 76-81
16. T. Araki SPIO-MRI in the detection of hepatocellular carcinoma J Gastroenterol 35 2000 874-876
17. H. Nakamura N. Ito F. Kotake Y. Mizokami T. Matsuoka Tumor-detecting capacity and clinical usefulness of SPIO-MRI in patients with hepatocellular carcinoma J Gastroenterol 35 2000 849-855
18. M. Stiskal H.C. Schwickert F. Demsar T.P. Roberts D. Szolar R. Weissleder et al. Contrast enhancement in experimental radiation-induced liver injury: Comparison of hepatocellular and reticuloendothelial particulate contrast agents J Magn Reson Imaging 6 1996 286-290
19. R. Weissleder P. Reimer A.S. Lee J. Wittenberg T.J. Brady MR receptor imaging: Ultrasmall iron oxide particles targeted to asialoglycoprotein receptors AJR Am J Roentgenol 155 1990 1161-1167
20. P. Reimer R. Weissleder T.J. Brady A.E. Yeager B.H. Baldwin B.C. Tennant et al. Experimental hepatocellular carcinoma: MR receptor imaging Radiology 180 1991 641-645
21. R. Weissleder G. Elizondo J. Wittenberg A.S. Lee L. Josephson T.J. Brady Ultrasmall superparamagnetic iron oxide: An intravenous contrast agent for assessing lymph nodes with MR imaging Radiology 175 1990 494-498
22. B.C. Nguyen W. Stanford B.H. Thompson N.P. Rossi K.H. Kernstine J.A. Kern et al. Multicenter clinical trial of ultrasmall superparamagnetic iron oxide in the evaluation of mediastinal lymph nodes in patients with primary lung carcinoma J Magn Reson Imaging 10 1999 468-473
23. M.G. Harisinghani J. Barentsz P.F. Hahn W.M. Deserno S. Tabatabaei C.H. van de Kaa et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer N Engl J Med 348 2003 2491-2499
24. P. Vassallo C. Matei W.D. Heston S.J. McLachlan J.A. Koutcher R.A. Castellino AMI-227-enhanced MR lymphography: Usefulness for differentiating reactive from tumor-bearing lymph nodes Radiology 193 1994 501-506
25. P. Vassallo C. Matei W.D. Heston S.J. McLachlan J.A. Koutcher R.A. Castellino Characterization of reactive versus tumor-bearing lymph nodes with interstitial magnetic resonance lymphography in an animal model Invest Radiol 30 1995 706-711
26. F. Rety O. Clement N. Siauve C.A. Cuenod F. Carnot M. Sich et al. MR lymphography using iron oxide nanoparticles in rats: Pharmacokinetics in the lymphatic system after intravenous injection J Magn Reson Imaging 12 2000 734-739
27. M.G. Torchia R. Nason R. Danzinger J.M. Lewis J.A. Thliveris Interstitial MR lymphangiography for the detection of sentinel lymph nodes J Surg Oncol 78 2001 151-156
28. M.G. Harisinghani W.T. Dixon M.A. Saksena E. Brachtel D.J. Blezek P.J. Dhawale et al. MR lymphangiography: Imaging strategies to optimize the imaging of lymph nodes with ferumoxtran-10 Radiographics 24 2004 867-878
29. J.W. Bulte M.W. de Jonge R.L. Kamman F. Zuiderveen T.H. The L. de Leij et al. Magnetite as a potent contrast-enhancing agent in magnetic resonance imaging to visualize blood-brain barrier disruption Acta Neurochir Suppl (Wien) 57 1993 30-34
30. E. Schulze J.T. Ferrucci Jr K. Poss L. Lapointe A. Bogdanova R. Weissleder Cellular uptake and trafficking of a prototypical magnetic iron oxide label in vitro Invest Radiol 30 1995 604-610
31. A. Moore R. Weissleder A. Bogdanov Jr Uptake of dextran-coated monocrystalline iron oxides in tumor cells and macrophages J Magn Reson Imaging 7 1997 1140-1145
32. S.G. Ruehm C. Corot P. Vogt H. Cristina J.F. Debatin Ultrasmall superparamagnetic iron oxide-enhanced MR imaging of atherosclerotic plaque in hyperlipidemic rabbits Acad Radiol 9 Suppl 1 2002 S143-S144
33. M.E. Kooi V.C. Cappendijk K.B. Cleutjens A.G. Kessels P.J. Kitslaar M. Borgers et al. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging Circulation 107 2003 2453-2458
34. S. Kanno Y. Wu P. Lee S. Dodd M. Williams B. Griffith et al. Macrophage accumulation associated with rat cardiac allograft rejection detected by magnetic resonance imaging with ultrasmall superparamagnetic iron oxide particles Circulation 104 2001 934-938
35. J.W. Bulte S. Zhang P. van Gelderen V. Herynek E.K. Jordan I.D. Duncan et al. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: Magnetic resonance tracking of cell migration and myelination Proc Natl Acad Sci U S A 96 1999 15256-15261
36. J. Bulte T. Douglas B. Witwer S. Zhang B. Lewis P. van Gelderen et al. Monitoring stem cell therapy in vivo using magnetodendrimers as a new class of cellular MR contrast agents Acad Radiol 9 Suppl 2 2002 S332-S335
37. J.A. Frank B.R. Miller A.S. Arbab H.A. Zywicke E.K. Jordan B.K. Lewis et al. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents Radiology 228 2003 480-487
38. C. Wilhelm C. Billotey J. Roger J.N. Pons J.C. Bacri F. Gazeau Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating Biomaterials 24 2003 1001-1011
39. S.A. Anderson J. Glod A.S. Arbab M. Noel P. Ashari H.A. Fine et al. Non-invasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model Blood 2004 (prepublished online August 26, 2004; DOI 10.1182/Blood-2004-06-2222)
40. M. Lewin N. Carlesso C.H. Tung X.W. Tang D. Cory D.T. Scadden et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells Nat Biotechnol 18 2000 410-414
41. L. Josephson C.H. Tung A. Moore R. Weissleder High efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates Bioconjug Chem 10 1999 186-191
42. J.R. Allport R. Weissleder In vivo imaging of gene and cell therapies Exp Hematol 29 2001 1237-1246
43. P. Wunderbaldinger L. Josephson R. Weissleder Tat peptide directs enhanced clearance and hepatic permeability of magnetic nanoparticles Bioconjug Chem 13 2002 264-268
44. A. Moore J. Grimm B. Han P. Santamaria Tracking the recruitment of diabetogenic CD+ T-cells to the pancreas in real time Diabetes 53 2004 1459-1466
45. R. Weissleder A.S. Lee B.A. Khaw T. Shen T.J. Brady Antimyosin-labeled monocrystalline iron oxide allows detection of myocardial infarct: MR antibody imaging Radiology 182 1992 381-385
46. C.H. Dodd H.C. Hsu W.J. Chu P. Yang H.G. Zhang J.D. Mountz Jr et al. Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator-peptide-derived superparamagnetic nanoparticles J Immunol Methods 256 2001 89-105
47. H.W. Kang L. Josephson A. Petrovsky R. Weissleder A. Bogdanov Jr Magnetic resonance imaging of inducible E-selectin expression in human endothelial cell culture Bioconjug Chem 13 2002 122-127
48. E.A. Schellenberger A. Bogdanov Jr D. Hogemann J. Tait R. Weissleder L. Josephson Annexin V-CLIO: A nanoparticle for detecting apoptosis by MRI Mol Imaging 1 2002 102-107
49. L.O. Johansson A. Bjornerud H.K. Ahlstrom D.L. Ladd D.K. Fujii A targeted contrast agent for magnetic resonance imaging of thrombus: implications of spatial resolution J Magn Reson Imaging 13 2001 615-618
50. D. Artemov N. Mori B. Okollie Z.M. Bhujwalla MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles Magn Reson Med 49 2003 403-408
51. B.A. Moffat G.R. Reddy P. McConville D.E. Hall T.L. Chenevert R.R. Kopelman et al. A novel polyacrylamide magnetic nanoparticle contrast agent for molecular imaging using MRI Mol Imaging 2 2003 324-332
52. R.M. Botnar A.S. Perez S. Witte A.J. Wiethoff J. Laredo J. Hamilton et al. In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent Circulation 109 2004 2023-2029
53. Z.A. Fayad MR imaging for the noninvasive assessment of atherothrombotic plaques Magn Reson Imaging Clin N Am 11 2003 101-113
54. G. Lanza C. Lorenz S. Fischer M. Scott W. Cacheris R. Kaufman et al. Enhanced detection of thrombi with a novel fibrin-targeted magnetic resonance imaging agent Acad Radiol 5 Suppl 1 1998 s173-s176
55. S. Flacke S. Fischer M. Scott R. Fuhrhop J. Allen M. McLean et al. A novel MRI contrast agent for molecular imaging of fibrin: Implications for detecting vulnerable plaques Circulation 104 2001 1280-1285
56. P. Winter S. Caruthers X. Yu S. Song R. Fuhrhop J. Chen et al. Improved molecular imaging contrast agent for detection of human thrombus Mag Reson Med 50 2003 411-416
57. A.M. Morawski P.M. Winter K.C. Crowder S.D. Caruthers R.W. Fuhrhop M.J. Scott et al. Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI Magn Reson Med 51 2004 480-486
58. P.M. Winter S.D. Caruthers A. Kassner T.D. Harris L.K. Chinen J.S. Allen et al. Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(v)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging Cancer Res 63 2003 5838-5843
59. P.M. Winter A.M. Morawski S.D. Caruthers R.W. Fuhrhop H. Zhang T.A. Williams et al. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles Circulation 108 2003 2270-2274
60. G.M. Lanza X. Yu P.M. Winter D.R. Abendschein K.K. Karukstis M.J. Scott et al. Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent: Implications for rational therapy of restenosis Circulation 106 2002 2842-2847
61. S. Fossheim A. Fahlvik J. Klaveness R. Muller Paramagnetic liposomes as MRI contrast agents: Influence of liposomal physicochemical properties on the in vitro relaxivity Magn Reson Imaging 17 1999 83-89
62. S.H. Koenig Q.F. Ahkong R.D. Brown III M. Lafleur M. Spiller E. Unger et al. Permeability of liposomal membranes to water: Results from the magnetic field dependence of T1 of solvent protons in suspensions of vesicles with entrapped paramagnetic ions Magn Reson Med 23 1992 275-286
63. C.W. Grant S. Karlik E. Florio A liposomal MRI contrast agent: phosphatidylethanolamine-DTPA Magn Reson Med 11 1989 236-243
64. G. Kabalka M. Davis E. Holmberg K. Maruyama L. Huang Gadolinium-labeled liposomes containing amphiphilic Gd-DTPA derivatives of varying chain length: Targeted MRI contrast enhancement agents for the liver Magn Reson Imaging 9 1991 373-377
65. D.A. Sipkins D.A. Cheresh M.R. Kazemi L.M. Nevin M.D. Bednarski K.C. Li Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging Nat Med 4 1998 623-626
66. J.D. Hood D.A. Cheresh Targeted delivery of mutant Raf kinase to neovessels causes tumor regression Cold Spring Harb Symp Quant Biol 67 2002 285-291
67. J.D. Hood M. Bednarski R. Frausto S. Guccione R.A. Reisfeld R. Xiang et al. Tumor regression by targeted gene delivery to the neovasculature Science 296 2002 2404-2407